Rapidly infusing cannabinoid compositions, processes of manufacture, and methods of use

Abstract

A rapidly infusing composition that includes (a) a pharmaceutically acceptable binder and/or excipient system containing gelatin and a sugar alcohol, and (b) active therapeutic ingredient (ATI). Preferred rapidly infusing compositions are those formulated with tetrahydrocannabinol or a derivative/analog thereof as the ATI. A process for manufacturing the rapidly infusing composition and a method of administering an ATI such as tetrahydrocannabinol or a derivative/analog thereof, to a subject is also disclosed. The subject is administered the rapidly infusing composition via the oral mucosa to activate cannabinoid receptors in the subject, for example to treat conditions such as, inter alia, anorexia, cachexia, nausea, emesis, pain, spasticity, fibromyalgia, overactive bladder, sleep apnea, and/or glaucoma.

Dependencies are inferred from the claim text.